Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Secondary Acute Myeloid Leukemia: Demographic, Physiopathogenic, Clinical and Therapeutic Comparative Study

Roberto Ovilla, MD, Renee Leonor Crisp, PhD, Pamela E Baez-Islas, MD, Jorge A Arbelbide, MD, Sofia Grille, MD PhD, Lilián Díaz, MD, Henry Idrobo, MD Professor, Alicia Enrico, MD, Maria J Mela Osorio, MD, Isolda I. Fernandez, MD, Luciana C Ferrari, MD, Nidia Zapata, MD, Adrian A Ceballos-Lopez, Veronica Mena, MD, Ana L Romero, MD, Juan Carlos Serrano, MD, Gabriela Vidal-Senmache, MD, Fernando Barroso Duarte, MD, Edit N Pintos, MD, Mariana Rosenhain, MD, Laura Kornblihtt, MD, Natalia Tejeira, MD, Breno Gusmao, MD, Maria Elena Del Rocio Buenaño, MD, Marcos Di Stefano, MD, Matilde Boada, MD, Alberto Gimenez Conca, MD, Maria Perusini, MD, Hernan Dick, MD, Santiago Cranco, MD, Maria Lucia Fuente, Alicia Beatriz Navickas, MD, Maria M Moirano, MD, Natalia Oliveira, MD, Jacqueline Gonzalez, MD, Mariana Bandín, MD, Noelia Villaverde, MD, Alejandro Suero, MD, Juan Felipe Lasso, MD, Nora Carrara, MD, Xochitl Cota, MD, Carolina Lazzarino, MD, Maria Leticia Rapan, MD, Marcelo Iastrebner, MD, Latin-American MDS Group (GLAM), MDS and Acute Leukemia Sub-Commission Group Argentinian Society of Hematology

Blood (2019) 134 (Supplement_1): 5096.

https://doi.org/10.1182/blood-2019-125311

Published: 2019

Journal Articles

Efficacy of Daratumumab in Combination with Standard of Care Regimens in Lenalidomide-Exposed or -Refractory Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Analysis of the Castor, Pollux, and MMY1001 Studies

Blood (2018) 132 (Supplement 1): 3288.

https://doi.org/10.1182/blood-2018-99-112669

Published: 2018

Journal Articles

Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed/Refractory Multiple Myeloma (RRMM) Patients: An Update of Overall Survival in Castor

Suzanne Lentzsch, Hang Quach, MBBS, MD, Asher A. Chanan-Khan, MD, Noemi Horvath, FRACP, Marcelo Capra, MD PhD, Roberto Ovilla, MD, Jae-Cheol Jo, MD, Ho-Jin Shin, MD, Piruntha Thiyagarajah, Himal Amin, Tineke Casneuf, PhD, Pieter Sonneveld, MDPhD, Jordan Schecter, Vania T M Hungria, MD PhD

Blood (2017) 130 (Supplement 1): 1852.

https://doi.org/10.1182/blood.V130.Suppl_1.1852.1852

Published: 2017

Journal Articles

Daratumumab, Bortezomib and Dexamethasone Versus Bortezomib and Dexamethasone Alone for Relapsed or Refractory Multiple Myeloma Based on Prior Treatment Exposure: Updated Efficacy Analysis of Castor

Asher A. Chanan-Khan, MD, Suzanne Lentzsch, MD PhD, Hang Quach, MBBS (Hons), FRACP, FRCPA, MD, Noemi Horvath, MB, ChB, FRACP, FRCPA, Marcelo Capra, MD PhD, Roberto Ovilla, MD PhD, Jae-Cheol Jo, MD PhD, Ho-Jin Shin, MD PhD, Ming Qi, William Deraedt, Jordan Schecter, Himal Amin, Xiang Qin, Tineke Casneuf, Christopher Chiu, A. Kate Sasser, Pieter Sonneveld, MD PhD

Blood (2016) 128 (22): 3313.

https://doi.org/10.1182/blood.V128.22.3313.3313

Published: 2016

Journal Articles

Results from a Hemato-Oncology Latin America Observational Registry (HOLA) Providing Real World Outcomes for the Treatment of Patients with NHL

Miguel A Pavlovsky, MD, Laura Fogliatto, MD, Gladys Patricia Agreda Vásquez, MD, Alicia Enrico, MD, María Jose Mela Osorio, MD, Jorge Antonio Armenta San-Sebastian, MD, Roberto Ovilla, MD PhD, Oscar Avendaño, MD, Lineth López, MD, Telma Santos, MD PhD, Odin De La Mora Estrada, MD

Blood (2016) 128 (22): 5327.

https://doi.org/10.1182/blood.V128.22.5327.5327

Published: 2016

Journal Articles

Experience of a Single Latin-American Institution Using a Colloidal Iron Oxide Coated with a Semisynthetic Carbohydrate (ferumoxytol) for Iron Deficiency Anemia (IDA) in Patients with Intolerance or Treatment Failure with Oral Iron

Roberto Ovilla, MD, Dannia Calles-Payan, MD, Lucia A Reynolds-Ocampo, MD, Gabriela Ruiz-Reyes, Nurse, Carolina Balderas-Delgado, MD, Andres Montesinos-Ovilla, Alvaro Cabrera Garcia, MD

Blood (2014) 124 (21): 4887.

https://doi.org/10.1182/blood.V124.21.4887.4887

Published: 2014

Journal Articles

Reduction in the Incidence and Severity of Graft Versus Host Disease in HLA-Matched and Haploidentical Bone Marrow Transplantation Using Posttrasplant Cyclophosphamide. Experience of Two Latino-American Institutions

Roberto Ovilla, MD, Uendy Perez-Lozano, MD, Dannia Calles-Payan, MD, Lucia A Reynolds-Ocampo, MD, Gabriela Ruiz-Reyes, Nurse, Carolina Balderas-Delgado, MD, Alvaro Cabrera Garcia, MD

Blood (2014) 124 (21): 5880.

https://doi.org/10.1182/blood.V124.21.5880.5880

Published: 2014

Journal Articles

Differences In Treatment and Diagnostic Patterns In Private Vs Public Sectors For Deletion 5Q Myelodysplastic Syndromes (MDS) In Mexico: Results From A Physician Survey

Michelle Ann Soriano, PhD, Roberto Ovilla, MD, Maria Guadalupe Rodríguez-González, MD, Renée Arnold, PharmD, RPh, Dalia Mahmoud, MBA

Blood (2013) 122 (21): 5593.

https://doi.org/10.1182/blood.V122.21.5593.5593

Published: 2013

Journal Articles

Successful Engrafment After HLA Identical Granulocyte Transfusion As Support Therapy in a Septic Shock Patient with Acute Lymphoblastic Leukemia

Roberto Ovilla, MD, Claudia Barrera-Carmona, MD, Nicolas Guzman-Bouilloud, MD, Elizabeth Buganza-Torio, MD, Rosa Jimenez-Alvarado, MD, Claudia Monreal-Alcantara, MD

Blood (2012) 120 (21): 4507.

https://doi.org/10.1182/blood.V120.21.4507.4507

Published: 2012

Journal Articles

5-Azacitidine Plus Vorinostat As Maintenance Therapy of Second Remission in AML Instead of High Doses of Consolidation with Cytarabine

Roberto Ovilla, MD, Claudia Barrera-Carmona, MD, Nicolas Guzman-Bouilloud, MD, Elizabeth Buganza-Torio, MD, Rosa Jimenez-Alvarado, MD, Claudia Monreal-Alcantara, MD

Blood (2012) 120 (21): 4348.

https://doi.org/10.1182/blood.V120.21.4348.4348

Published: 2012

Journal Articles

Compassionate Use Program (CUP) with Ruxolitinib in Mexican Patients with Primary Myelofibrosis (PMF), Post – Polycythemia, Vera Myelofibrosis (PPV – MF), and Post–Essential Thrombocythemia Myelofibrosis (PET – MF)

Pablo Vargas, MD, Roberto Ovilla, MD, Martha Alvarado, MD, Manuel Lopez, MD, Rafael Hurtado Monroy, MD., Juan_Carlos Solis, MD, Alejandro Limon, MD, Gladys Agreda, MD, Salvador Silva, MD, Juan Julio Kassack, MD, Saida Zavala, MD, Carlos Aguilar, MD, Enrique Baez, Esperanza Barrera, MD, Antonio Osuna, MD, Javier Morales, MD, Aquileo Herrera, MD

Blood (2012) 120 (21): 5067.

https://doi.org/10.1182/blood.V120.21.5067.5067

Published: 2012

Journal Articles

Primary Prophylaxis Using Peg-Filgrastim Is Useful Preventing Severe Infections and Neutropenia in Patients Diagnosed with Non Hodgkin Lymphoma (NHL). Report of Latin America International Multicenter Study

Luis Villela, MD, Alberto Villalobos, MD, Gustavo Reyes-Brena, MD, Jorge Duque, MD, Juan Carlos Solís-Poblano, Eduardo Reynoso, MD, Roberto Ovilla, MD, Alejandro Camacho, MD, Norberto Vazquez, MD, Oscar Garces, Enrique Pedrasa, MD, Salvador Silva, MD

Blood (2008) 112 (11): 4663.

https://doi.org/10.1182/blood.V112.11.4663.4663

Published: 2008

Journal Articles

Succesful Treatment with Sirolimus in a Refractory Case of Pure Red Cell Aplasia (PRCA).

Roberto Ovilla, MD

Blood (2007) 110 (11): 3778.

https://doi.org/10.1182/blood.V110.11.3778.3778

Published: 2007

NARROW

Secondary Acute Myeloid Leukemia: Demographic, Physiopathogenic, Clinical and Therapeutic Comparative Study

Efficacy of Daratumumab in Combination with Standard of Care Regimens in Lenalidomide-Exposed or -Refractory Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Analysis of the Castor, Pollux, and MMY1001 Studies

Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed/Refractory Multiple Myeloma (RRMM) Patients: An Update of Overall Survival in Castor

Daratumumab, Bortezomib and Dexamethasone Versus Bortezomib and Dexamethasone Alone for Relapsed or Refractory Multiple Myeloma Based on Prior Treatment Exposure: Updated Efficacy Analysis of Castor

Results from a Hemato-Oncology Latin America Observational Registry (HOLA) Providing Real World Outcomes for the Treatment of Patients with NHL

Experience of a Single Latin-American Institution Using a Colloidal Iron Oxide Coated with a Semisynthetic Carbohydrate (ferumoxytol) for Iron Deficiency Anemia (IDA) in Patients with Intolerance or Treatment Failure with Oral Iron

Reduction in the Incidence and Severity of Graft Versus Host Disease in HLA-Matched and Haploidentical Bone Marrow Transplantation Using Posttrasplant Cyclophosphamide. Experience of Two Latino-American Institutions

Differences In Treatment and Diagnostic Patterns In Private Vs Public Sectors For Deletion 5Q Myelodysplastic Syndromes (MDS) In Mexico: Results From A Physician Survey

Successful Engrafment After HLA Identical Granulocyte Transfusion As Support Therapy in a Septic Shock Patient with Acute Lymphoblastic Leukemia

5-Azacitidine Plus Vorinostat As Maintenance Therapy of Second Remission in AML Instead of High Doses of Consolidation with Cytarabine

Compassionate Use Program (CUP) with Ruxolitinib in Mexican Patients with Primary Myelofibrosis (PMF), Post – Polycythemia, Vera Myelofibrosis (PPV – MF), and Post–Essential Thrombocythemia Myelofibrosis (PET – MF)

Primary Prophylaxis Using Peg-Filgrastim Is Useful Preventing Severe Infections and Neutropenia in Patients Diagnosed with Non Hodgkin Lymphoma (NHL). Report of Latin America International Multicenter Study

Succesful Treatment with Sirolimus in a Refractory Case of Pure Red Cell Aplasia (PRCA).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only